SITUATE

Description of Event or Problem

ACCORDING TO THE REPORTER, DURING A TOTAL HIP REPLACEMENT PROCEDURE, THE SPONGE WAS NOT DETECTED BUT IT WAS PRESENT. WHILE CLOSING THE INCISION THE SURGICAL COUNT WAS INCORRECT, THEY WERE MISSING A RAYTEC SPONGE. THE NEXT STEP IS TO INFORM THE SURGEON ABOUT THE MISSING RAYTEC AND USE THE RFID TO WAND THE INCISION. A STERILE DRAPE WAS PLACED OVER THE WAND AND THE RFID WAS USED TO WAND OVER THE INCISION ON THE HIP. THE DEVICE DID NOT DETECT E SPONGE INCISE THE HIP. THEY THEN USED THE RFID ON THE TRASH AND THE RFID DID NOT DETECT THE MISSING RAYTEC. THEN THE WAND WAS USED OVER THE NINE RAYTEC SPONGES THAT NOT MISSING. THE RFID DID DETECT THE RAYTECS. THE TEAM WAS REASSURED THAT THE RFID WAS WORKING. THE TEAM THEN TRIED AGAIN TO USE THE RFID OVER THE SURGICAL SITE AND IT DID NOT DETECT THE RAYTEC. THE SURGEON THEN ENTERED THE ROOM AND INSTRUCTED THE PHYSICIAN ASSISTANT TO OPEN THE SURGICAL SITE WOUND BACK UP TO CHECK FOR THE RAYTEC. ONCE THE WOUND WAS OPENED THE RAYTEC SPONGE WAS LOCATED INSIDE THE PATIENT'S HIP. AFTER THE RAYTEC WAS REMOVED AND THE COUNTS WERE NOW COMPLETE THEY USED THE RFID TO WAND OVER THE SPONGE THAT WAS INSIDE THE PATIENT, THE RFID STILL DID NOT DETECT THE SPONGE. THE ONLY TIME THE RAYTEC WAS DETECTED BY THE RFID WAS WHEN THE WAND WAS PLACED DIRECTLY ON THE SPONGE. PROCEDURE HAD EXTENDED TIME.

Additional Manufacturer Narrative

D10 CONCOMITANT PRODUCT: L1818-04P01C-1, L1818-04P01C-1 LAP XRAY RF 18X18 ST (LOT#UNKNOWN). MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative

ADDITIONAL INFORMATION: G3 CORRECTION: D1, D2, D4(MODEL NUMBER, CATALOG NUMBER AND UDI), D8, PMA / 510(K) # D10 CONCOMITANT PRODUCT: UNKNOWN WAND, UNKNOWN WAND (SERIAL#UNKNOWN) MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.